Investment
Features
FeesSafety
Academy
More
Pluang+

Oxbridge Re reports strong 2025 results, expands blockchain partnerships, and targets high returns for 2026–27 tokenized reinsurance.

Company Fundamentals
30 Mar 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

Oxbridge Re Holdings Limited announced robust financial results for 2025, with its tokenized reinsurance products exceeding return targets—Balanced Yield Token now expected to yield 25% annually, and High Yield Token on track for 42%. The company expanded its platform through strategic partnerships with Alphaledger and LayerZero, enabling distribution across 160+ blockchain networks. Despite increased expenses and losses related to Hurricane Milton, Oxbridge Re is preparing for the 2026–27 contract cycle with new offerings targeting similar high returns and exploring tokenization of additional assets like data center revenues. Management believes the current market valuation undervalues the company’s strong balance sheet and growth prospects.

More News

Barclays raises Hudbay Minerals price target to $32 on strong copper growth outlook.

Barclays raises Hudbay Minerals price target to $32 on strong copper growth outlook.

Barclays increased its price target for Hudbay Minerals to $32 from $30, citing strong growth prospects in copper mining. Despite a recent nearly 30% stock pullback due to market sentiment, Hudbay maintains a solid financial position with near-zero n...

Analyst Insights
Bullish
50 minutes ago
Morgan Stanley beats Q2 earnings and revenue estimates with strong divisional growth.

Morgan Stanley beats Q2 earnings and revenue estimates with strong divisional growth.

Morgan Stanley reported strong Q2 2026 results, with earnings per share of $3.46 surpassing estimates of $2.89 and revenue of $21.35 billion beating forecasts of $19.67 billion. This marks significant year-over-year growth from $16.79 billion, driven...

Company Fundamentals
Bullish
53 minutes ago
Autoimmune therapeutics market to reach $137.85B by 2035, driven by biologics and precision medicine growth

Autoimmune therapeutics market to reach $137.85B by 2035, driven by biologics and precision medicine growth

The global autoimmune disease therapeutics market is projected to grow from $80.54 billion in 2025 to $137.85 billion by 2035, at a CAGR of 5.52%. Growth is fueled by rising autoimmune disease prevalence, advances in biologics, JAK inhibitors, monocl...

Market News
Bullish
54 minutes ago
Light Up Chinatown! 2026 festival returns to Vancouver with food, music, and community events on August 8-9.

Light Up Chinatown! 2026 festival returns to Vancouver with food, music, and community events on August 8-9.

The Vancouver Chinatown Foundation and RBC are hosting Light Up Chinatown! 2026, a free two-day festival on August 8-9 along Columbia Street in Vancouver’s Chinatown. The event features exclusive food collaborations, live music performances, family a...

Others
Neutral
54 minutes ago
Travelers are more strategic with rewards programs, seeking value and ease amid rising loyalty challenges.

Travelers are more strategic with rewards programs, seeking value and ease amid rising loyalty challenges.

New research from iSeatz reveals that U.S. travelers are increasingly strategic about travel rewards programs, with 40% treating them as financial optimization tools and 60% belonging to multiple programs. Despite high enrollment, many travelers find...

Others
Neutral
54 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App